Search Results for agency_names:"Centers for Disease Control and Prevention"

The Centers for Disease Control and Prevention (CDC) has submitted a request to the Office of Management and Budget (OMB) for reviewing a data collection project titled “Characteristics of Cases of Priority Fungal Diseases.” This project aims to gather data on various fungal diseases to better understand their impact, spread, and risk factors across the U.S. Interested parties are invited to comment on this project, with special interest in evaluating its necessity, burden, and potential improvements. The CDC stresses the importance of this data for guiding public health responses, especially regarding high-risk populations and emerging disease trends.

The Centers for Disease Control and Prevention (CDC) and the Health and Human Services Department announced a closed meeting of the Disease, Disability, and Injury Prevention and Control Special Emphasis Panel scheduled for April 13-14, 2021. The meeting, which will be held via teleconference, aims to review and evaluate grant applications related to public health research in countries like Bangladesh, Thailand, Kenya, and others. The sessions are closed to the public to protect sensitive information, such as trade secrets and personal data about individuals involved in the grant applications. For more details, contact Dr. Hylan Shoob at the CDC.

The Centers for Disease Control and Prevention (CDC) announced an upcoming meeting of the Advisory Committee on Immunization Practices (ACIP) on February 24-25, 2021. The meeting will cover a range of vaccines, including those for cholera, hepatitis B, influenza, and rabies, and will be webcasted live for public access. Public comments can be submitted in writing by February 25 and there will be an opportunity for oral comments, with priority given to prior requests. The ACIP provides recommendations on the use of vaccines, contributing to public health policy and insurance coverage mandates.

The Centers for Disease Control and Prevention (CDC) has announced a closed meeting for the Disease, Disability, and Injury Prevention and Control Special Emphasis Panel. The meeting, scheduled for April 29, 2021, will be held via teleconference from 11:00 a.m. to 6:00 p.m. EDT to review and evaluate grant applications. The session is closed to the public to protect trade secrets, confidential commercial property, and personal privacy. Dr. Jaya Raman serves as the Scientific Review Officer and can be contacted for more information.

The Centers for Disease Control and Prevention (CDC) and the Agency for Toxic Substances and Disease Registry have announced a closed meeting. Marilyn Ridenour is the contact person for any further information regarding the meeting, and she can be reached at the CDC's National Institute for Occupational Safety and Health. Kalwant Smagh, serving as the Director of the Strategic Business Initiatives Unit, is authorized to sign Federal Register notices related to meetings and other management activities for these agencies.

The Centers for Disease Control and Prevention (CDC) is seeking public comments on an information collection project called the "National Syringe Services Program (SSP) Evaluation." This project aims to assess the operation and effectiveness of SSPs, which provide services to individuals who inject drugs, in order to reduce the spread of infectious diseases. The survey will be voluntary and will take approximately 35 minutes to complete. The CDC hopes to gather detailed information from SSPs across the nation to improve program quality and effectiveness.

The Centers for Disease Control and Prevention (CDC), part of the Department of Health and Human Services, is seeking public comments on a project related to the Preventive Health and Health Services Block Grant (PHHS BG). This project focuses on collecting information to assess the impact and outcomes of the funding provided through the grant program. The data collected will help CDC understand how these funds improve public health efforts and support future funding requests. Comments on this data collection are open until February 4, 2025, and the collection process will use a web-based tool for voluntary responses from health departments.

The Centers for Disease Control and Prevention (CDC) has submitted an information collection request regarding "COVID-19 Pandemic Response, Laboratory Data Reporting" to the Office of Management and Budget (OMB) for approval, as required by the Paperwork Reduction Act of 1995. This proposed data collection aims to gather comprehensive laboratory testing data to aid in the public health response to the COVID-19 pandemic by tracking disease trends, facilitating contact tracing, and managing testing resources. The CDC is inviting public comments for an additional 30 days to ensure this collection is efficient, clear, and minimally burdensome. Interested individuals can comment on the necessity and accuracy of the data collection or contribute suggestions for improvement.

Notice has been given for a closed meeting of the Disease, Disability, and Injury Prevention and Control Special Emphasis Panel on February 24-25, 2025. The Centers for Disease Control and Prevention (CDC) will use a video-assisted format to review grant applications related to Occupational Safety and Health Education and Research Centers. The meeting will remain private to protect trade secrets and personal information. Concerns or inquiries can be directed to Dr. Michael Goldcamp, the Scientific Review Officer at the CDC.

The Centers for Disease Control and Prevention (CDC) has announced a proposed data collection project called Combating Antimicrobial Resistant Gonorrhea and Other STIs (CARGOS). This initiative aims to improve the detection, monitoring, and response to antimicrobial resistance in sexually transmitted infections, particularly focusing on Neisseria gonorrhoeae, which is developing resistance to current treatments. Public comments on this proposal can be submitted until March 10, 2025, as part of the requirements under the Paperwork Reduction Act. The project involves local health departments and clinics collecting and sharing data on gonorrhea cases to better understand and address resistance, with CDC ensuring data privacy and security.